Alpha-galactosidase: use with food

How to read enzyme activity and which foods were studied with it.

Key points

  • Alpha-galactosidase breaks down certain GOS carbohydrates in legumes, soy and some nuts. A different enzyme, lactase, is used for milk sugar. [1] [2] [3] See the evidence 1 2
  • In a study, adults took an enzyme solution with a legume meal and passed gas less often during the following six hours than with placebo. The authors did not report the numerical difference for the whole period. [2] See the evidence 1
  • On the package, compare enzyme activity in GalU or FCC GalU: the mass of the preparation alone does not indicate this activity. A Canadian monograph for adults specifies taking it with the first bite of food. [1] [2] [3] See the evidence 1

Practical guide

Check the conclusions and their applicability to your situation.

The enzyme was studied with meals containing certain carbohydrates, including legumes.

Key points

Why these conclusions

Enzyme, food and dosage

Beans, chickpeas, lentils, soy and some nuts contain GOS. Fructans and polyols differ from GOS; the result of a single enzyme does not describe the effect of a multicomponent blend. [1] [2] [3]

For adults, the Canadian monograph describes 260–3,000 FCC GalU daily and use with the first bite of food. This is a labelling range, not a dietary reference intake or an established safety limit. [1] [2] [3]

In a trial of Beano solution, eight drops were given with the first bite and another eight with each subsequent cup of chilli. After the legume meal, gas was passed less often over six hours; the exact difference for the period was not reported, and confidence is low: 2 out of 4. [2] [1] [3]

Information from the source

NameDescriptionSources
Single enzyme or blendAlpha-galactosidase breaks down GOS. A different enzyme, lactase, is used for lactose, the sugar in milk. Fructans and polyols also differ from GOS; the result of alpha-galactosidase alone does not describe the effect of a multicomponent blend.[1] [3]
Drops, tablets and capsulesCompare the activity in GalU or FCC GalU shown on the label. For adults aged 18 and over, the Canadian monograph gives 260–3,000 FCC GalU daily to reduce gas and specifies taking it with the first bite of food. This is a product-labelling range under the monograph, not a dietary reference intake or an established safety limit.[3]
Beano solution in the study after a legume mealIn the experiment, eight drops were given with the first bite and another eight with each subsequent one-cup serving of chilli. Therefore eight drops do not represent the total dose for the whole meal.[2]

Information from the source

Beans, chickpeas, lentils, soy and some nuts contain GOS, carbohydrates on which alpha-galactosidase acts. The composition of the meal, portion size and tolerability matter here. The enzyme was studied as a supplement taken during a meal, so this list describes its dietary role, not ways to obtain a daily enzyme dose. [1] [3]

Information from the source

For diabetes, pregnancy and breastfeeding, the Canadian monograph calls for consultation with a doctor or pharmacist before use. It also recommends seeking advice for prolonged use and if symptoms persist or worsen. Stop use if an allergic reaction occurs. In a 12-week study in irritable bowel syndrome, 18 participants withdrew from the enzyme group and seven from the placebo group. Abdominal pain and diarrhoea were more often cited as reasons for stopping the enzyme. This observation does not establish that every case was caused by the supplement. No adverse events were recorded among 52 children in a two-week trial. This short observation does not establish the safety of long-term use. The paediatric regimens describe the specific Sinaire product; its number of drops or tablets cannot be transferred to another product. [4] [5] [3]

After a legume meal, episodes of passing gas occurred less often over six hours than with placebo. The authors did not report a numerical difference for the whole period; the result is shown in an hourly graph.

ParameterData
ResultAfter a legume meal, episodes of passing gas occurred less often over six hours than with placebo. The authors did not report a numerical difference for the whole period; the result is shown in an hourly graph.
Participants19 adults completed both meals out of 30 participants enrolled
FormBeano solution
Dose8 drops with the first bite and with each subsequent one-cup serving of chilli; 8 drops were not a fixed dose for the whole meal
Dose basis8 drops with the first bite and with each subsequent one-cup serving of chilli; 8 drops were not a fixed dose for the whole meal
ComparisonPlacebo
DurationOne meal and 6 hours of observation in each of two periods
Confidence2/4: Both meals were completed by 19 of the 30 participants enrolled. Loss of some participants limits the reliability of the comparison. Only six hours after one meal were observed; the article does not report the exact mean difference for the whole period.
Volume of evidence1 publication about one trial
Sources[2]

More details

Safety

For diabetes, pregnancy and breastfeeding, the Canadian monograph calls for consultation with a doctor or pharmacist before use. Stop use if an allergic reaction occurs. [4] [5] [3]

Sources

  1. Innovative concepts in diet therapies in disorders of gut-brain interaction. https://pubmed.ncbi.nlm.nih.gov/39027160/
  2. Does Beano prevent gas? A double-blind crossover study of oral alpha-galactosidase to treat dietary oligosaccharide intolerance. https://cdn.mdedge.com/files/s3fs-public/jfp-archived-issues/1994-volume_38-39/JFP_1994-11_v39_i5_does-beano-prevent-gas-a-double-blind-cr.pdf
  3. Alpha-Galactosidase — Natural Health Product Monograph, 10 January 2025 (Health Canada). https://webprod.hc-sc.gc.ca/nhpid-bdipsn/dbImages/mono_galactosidase-alpha_english.pdf
  4. Efficacy and tolerability of α-galactosidase in treating gas-related symptoms in children: a randomized, double-blind, placebo controlled trial. https://pubmed.ncbi.nlm.nih.gov/24063420/
  5. Does oral α-galactosidase relieve irritable bowel symptoms?. https://pubmed.ncbi.nlm.nih.gov/26133538/

Methodology: Subpages evidence-led supplement pipeline v1

Ingredient overview: Alpha-galactosidase